Company news

Photocure Asa (OSL:PHO) news

Every Photocure Asa press release and news update in one place — announcements, filings coverage, and company updates for investors.

View Photocure Asa stock analysis →

Press releases & updates

Cost neutrality of BLC versus WLC in a real-world setting demonstrated by new OPTUM study in the U.S.

August 11, 2026

Photocure ASA: Results for the second quarter of 2026

July 29, 2026

Photocure ASA to Acquire Vesica Health Inc., Strengthening Leadership in Bladder Cancer Diagnostics

June 4, 2026

AUA 2026: new studies demonstrated Blue Light Cystoscopy benefits in high-risk NMIBC management and cost comparison study

May 18, 2026

Photocure ASA: Results for the first quarter of 2026

May 7, 2026

New health economic methodology published: comparing cost-effectiveness of BLC versus NBI imaging technology in bladder cancer

May 4, 2026

Photocure ASA: Invitation to presentation of first quarter 2026 financial results

April 30, 2026

Photocure ASA: Update on Regulatory Classification for OAY Equipment

April 13, 2026

Photocure: Trials in Progress presented at the European Association of Urology (EAU) 2026 congress aim to enable a more personalized blad...

March 16, 2026

Asieris: CEVIRA Approved in China as First-in-Class Non-Invasive Therapy for Cervical Precancerous Lesions

March 3, 2026

Photocure partner Asieris announces that EMA has accepted Marketing Authorization Application for CEVIRA in Europe

February 27, 2026

Photocure ASA: Results for the fourth quarter of 2025

February 18, 2026

Photocure ASA: Invitation to presentation of 4th quarter and preliminary full year 2025 financial results

February 11, 2026

The impact of avoiding recurrence: New BRAVO Study abstract at SUO 2025 demonstrates Cost Neutrality in Blue Light versus White Light Cys...

December 8, 2025

New budget impact model study in 4 European countries concludes that BLC use offers a clinically meaningful and economically rational app...

November 19, 2025

Photocure ASA: Notification of primary insider transaction

October 31, 2025

Photocure ASA: Results for the third quarter of 2025

October 29, 2025

Photocure ASA: Invitation to presentation of third quarter 2025 financial results

October 24, 2025

Photocure and Intelligent Scopes Corporation partner on development of AI for blue light cystoscopy

October 15, 2025

Nokia expands defense portfolio with two advanced tactical communication solutions

September 9, 2025

Photocure ASA: Results for the second quarter of 2025

July 30, 2025

Photocure ASA: Results for the first quarter of 2025

May 8, 2025

Bladder Cancer presentations at AUA2025: Blue Light Cystoscopy improves risk stratification and informed decision making

April 29, 2025